Key result
Acute-to-chronic glycemic ratio linked to ~2.5-fold higher in-hospital adverse events in diabetic STEMI.
Why the study?
It was unknown whether the acute-to-chronic glycemic ratio provides better prognostic value than admission glycemia alone in patients with STEMI undergoing PCI.
Does the acute-to-chronic glycemic ratio (ABG/eAG) improve prognostic prediction compared to admission blood glucose alone for in-hospital outcomes in patients with STEMI undergoing PCI?
Observational (n=1,300)
No
Does the acute-to-chronic glycemic ratio (ABG/eAG) improve prognostic prediction compared to admission blood glucose alone for in-hospital outcomes in patients with STEMI undergoing PCI?
Answers are grounded in this paper and cite their sources.
The acute-to-chronic glycemic ratio is a better predictor of adverse in-hospital outcomes than admission blood glucose alone in diabetic patients presenting with STEMI and undergoing PCI.
This study investigated whether a novel index of stress hyperglycemia might have a better prognostic value compared to admission glycemia alone in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). The acute-to-chronic glycemic ratio was expressed as admission blood glucose (ABG) devided by the estimated average glucose (eAG), and eAG was derived from the glycated hemoglobin (HbA1c). A total of 1300 consecutive patients with STEMI treated with PCI were included. Baseline data and outcomes were analyzed. The study end point was a composite of in-hospital all-cause death, cardiogenic shock, and acute pulmonary edema. Accuracy was defined with area under the curve (AUC) by a receiver–operating characteristic (ROC) curve analysis. After multivariate adjustment, both ABG/eAG and ABG were closely associated with an increased risk of the composite end point in nondiabetic patients. However, only ABG/eAG (odds ratio = 2.45, 95% confidence interval: 1.24-4.82, P = .010), instead of ABG, was associated with the outcomes in diabetic patients. Compared to ABG, ABG/eAG had an equivalent predictive value in nondiabetic patients but a superior discriminatory ability in diabetic patients (AUC improved from 0.52-0.63, P < .001). Taken together, ABG/eAG provides more significant in-hospital prognostic information than ABG in diabetic patients with STEMI after PCI.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2019) conducted an observational in ST-Segment Elevation Myocardial Infarction (STEMI) (n=1,300). Acute-to-chronic glycemic ratio (ABG/eAG) vs. Admission blood glucose (ABG) alone was evaluated on Composite of in-hospital all-cause death, cardiogenic shock, and acute pulmonary edema (OR 2.45, 95% CI 1.24-4.82, p=0.010). The acute-to-chronic glycemic ratio was associated with an increased risk of in-hospital adverse events in diabetic STEMI patients and provided superior discriminatory ability compared to admission glucose alone.
Synapse has enriched 10 related papers. Consider them for comparative context: